RT @doctorRBC: Extended 5 year study of secukinumab in AS patients showed sustained improvement of back pain, nocturnal
Tweet Content
Extended 5 year study of secukinumab in AS patients showed sustained improvement of back pain, nocturnal back pain, AM stiffness, fatigue and LDA Abs#0364 @RheumNow #ACR20
Show on Archive Page
On
Display in Search Results
On